Nadroparin 5700 IU | Libya (BAYADERCARE)

Trusted anticoagulant solution for effective clot management.
NADROBARA Nadroparin 5700 IU prefilled syringe available in Libya through BAYADERCARE for therapeutic anticoagulation and thrombosis treatment
NADROBARA Nadroparin 5700 IU prefilled syringe available in Libya through BAYADERCARE for therapeutic anticoagulation and thrombosis treatment

Nadroparin 5700 IU Prefilled Syringe | BAYADERCARE Libya

Trusted anticoagulant solution for effective clot management.

Therapeutic anticoagulation is essential in managing moderate to high-risk thrombotic conditions, particularly in hospital and critical care settings where effective clot control and rapid clinical response are required. Low molecular weight heparins (LMWH) are widely utilized across Libyan healthcare systems due to their predictable anticoagulant profile and clinical reliability.

NADROBARA® (Nadroparin Injection) is developed by RAWIA INTERNATIONAL HEALTHCARE (RIHCA) in collaboration with leading pharmaceutical manufacturing partners and is available across Libya through BAYADERCARE. The 5700 IU strength is specifically positioned for therapeutic anticoagulation, supporting hospitals, intensive care units, and cardiovascular departments in Tripoli, Benghazi, Misrata, and across Libya — To Share • To Care • To Inspire.
NADROBARA® 5700 IU (Nadroparin Calcium) is a low molecular weight heparin (LMWH) designed for therapeutic anticoagulation in patients with active thromboembolic conditions. It works by inhibiting factor Xa activity, reducing clot formation and supporting effective blood circulation.
This strength is commonly used in the treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and other thrombotic disorders, particularly in moderate to high-risk patients under strict medical supervision.
Specifications Table
Parameter Details
Brand Name NADROBARA®
Generic Name Nadroparin Calcium
Arabic Name نادروبارا نادروبارين كالسيوم
Category Anticoagulants
Therapeutic Area Low Molecular Weight Heparin (LMWH)
Dosage Form Prefilled Syringe
Strength 5700 IU
Volume 0.6 ml
Route / Type Subcutaneous (Anti-Xa)
Developed By RIHCA
Marketed By RAWIACARE
Availability Libya via BAYADERCARE
Official Libya Proxy BAYADERCARE
Official Global Platform RAWIACARE / RAWIACARE GLOBAL
Corporate Philosophy TO SHARE • TO CARE • TO INSPIRE

Applications / Uses

Treatment of Deep Vein Thrombosis (DVT)
Management of Pulmonary Embolism (PE)
Therapeutic anticoagulation in high-risk patients
Cardiovascular and hospital-based treatment protocols
Intensive care (ICU) anticoagulant support
NADROBARA Nadroparin 2850 IU prefilled syringe available in Libya through BAYADERCARE for thrombosis prevention and anticoagulant therapy

Nadrobara Nadroparin Calcium 2850 IU Prefilled Syringe

Nadrobara Nadroparin Calcium 2850 IU Anti-Xa prefilled syringe for anticoagulant support and thrombosis management in hospitals and clinics in Libya.

NADROBARA Nadroparin 3800 IU prefilled syringe available in Libya through BAYADERCARE for anticoagulant therapy and thrombosis management

Nadrobara Nadroparin Calcium 3800 IU Prefilled Syringe

Nadrobara Nadroparin Calcium 3800 IU Anti-Xa prefilled syringe for anticoagulant support and thrombosis management in hospitals and clinics in Libya.

Nadrobara Nadroparin Calcium 5700 IU Prefilled Syringe

Nadrobara Nadroparin Calcium 5700 IU Anti-Xa prefilled syringe for anticoagulant support and thrombosis management in hospitals and clinics in Libya.

FAQ

Is NADROBARA 5700 IU available in Libya?

Yes, it is available through BAYADERCARE across Libya.

It is used for the treatment of thromboembolic conditions such as DVT and pulmonary embolism.

 

It inhibits factor Xa activity, reducing clot formation and supporting proper blood circulation.
Hospitals, intensive care units (ICU), cardiovascular departments, and specialized medical centers across Libya.

 

2850 IU
3800 IU
5700 IU

We Are Here to Support Your Healthcare Needs

Get in Touch
Add to cart